India limits trials per investigator but finite expert pool a concern

India has issued a string of new orders regarding clinical trials, including restricting the number of studies that an investigator can be involved in and an apparent tightening of the clause that permits a waiver of trials in the Indian population for new drugs already approved elsewhere.